Anthony Bunn
Corporate Secretary chez De Novo Pharmaceuticals Ltd.
Profil
Anthony John Bunn is currently working as a Secretary at De Novo Pharmaceuticals Ltd.
He previously worked as a Secretary at Sareum Holdings Plc.
Postes actifs de Anthony Bunn
| Sociétés | Poste | Début |
|---|---|---|
De Novo Pharmaceuticals Ltd.
 De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Corporate Secretary | 01/09/2000 |
Anciens postes connus de Anthony Bunn
| Sociétés | Poste | Fin |
|---|---|---|
| SAREUM HOLDINGS PLC | Corporate Secretary | 07/01/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAREUM HOLDINGS PLC | Miscellaneous |
| Entreprise privées | 1 |
|---|---|
De Novo Pharmaceuticals Ltd.
De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
